These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 15246568

  • 1. Analysis of p53 mutations in cells taken from paraffin-embedded tissue sections of ductal carcinoma in situ and atypical ductal hyperplasia of the breast.
    Keohavong P, Gao WM, Mady HH, Kanbour-Shakir A, Melhem MF.
    Cancer Lett; 2004 Aug 20; 212(1):121-30. PubMed ID: 15246568
    [Abstract] [Full Text] [Related]

  • 2. Analysis of loss of heterozygosity on chromosome 11q13 in atypical ductal hyperplasia and in situ carcinoma of the breast.
    Chuaqui RF, Zhuang Z, Emmert-Buck MR, Liotta LA, Merino MJ.
    Am J Pathol; 1997 Jan 20; 150(1):297-303. PubMed ID: 9006344
    [Abstract] [Full Text] [Related]

  • 3. p53 mutations in mammary ductal carcinoma in situ but not in epithelial hyperplasias.
    Done SJ, Arneson NC, Ozçelik H, Redston M, Andrulis IL.
    Cancer Res; 1998 Feb 15; 58(4):785-9. PubMed ID: 9485035
    [Abstract] [Full Text] [Related]

  • 4. Evidence of chromosomal alterations in pure usual ductal hyperplasia as a breast carcinoma precursor.
    Xu S, Wei B, Zhang H, Qing M, Bu H.
    Oncol Rep; 2008 Jun 15; 19(6):1469-75. PubMed ID: 18497952
    [Abstract] [Full Text] [Related]

  • 5. Quantitative analysis of allele imbalance supports atypical ductal hyperplasia lesions as direct breast cancer precursors.
    Larson PS, de las Morenas A, Cerda SR, Bennett SR, Cupples LA, Rosenberg CL.
    J Pathol; 2006 Jul 15; 209(3):307-16. PubMed ID: 16604511
    [Abstract] [Full Text] [Related]

  • 6. The timing and characterization of p53 mutations in progression from atypical ductal hyperplasia to invasive lesions in the breast cancer.
    Kang JH, Kim SJ, Noh DY, Choe KJ, Lee ES, Kang HS.
    J Mol Med (Berl); 2001 Nov 15; 79(11):648-55. PubMed ID: 11715068
    [Abstract] [Full Text] [Related]

  • 7. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
    Castro NP, Osório CA, Torres C, Bastos EP, Mourão-Neto M, Soares FA, Brentani HP, Carraro DM.
    Breast Cancer Res; 2008 Nov 15; 10(5):R87. PubMed ID: 18928525
    [Abstract] [Full Text] [Related]

  • 8. Nuclear cytometric changes in breast carcinogenesis.
    Mommers EC, Poulin N, Sangulin J, Meijer CJ, Baak JP, van Diest PJ.
    J Pathol; 2001 Jan 15; 193(1):33-9. PubMed ID: 11169513
    [Abstract] [Full Text] [Related]

  • 9. Immunohistochemical evaluation of c-erbB-2 oncogene expression in ductal carcinoma in situ and atypical ductal hyperplasia of the breast.
    Lodato RF, Maguire HC, Greene MI, Weiner DB, LiVolsi VA.
    Mod Pathol; 1990 Jul 15; 3(4):449-54. PubMed ID: 2170971
    [Abstract] [Full Text] [Related]

  • 10. Timing of critical genetic changes in human breast disease.
    Ellsworth RE, Ellsworth DL, Deyarmin B, Hoffman LR, Love B, Hooke JA, Shriver CD.
    Ann Surg Oncol; 2005 Dec 15; 12(12):1054-60. PubMed ID: 16228814
    [Abstract] [Full Text] [Related]

  • 11. [Expression and significance of hTERT mRNA in breast carcinoma and its relation to p53].
    Tang F, Gu DH, Wang H, Zhu TF, Zhu HG, Xu ZD, Hu XQ.
    Zhonghua Zhong Liu Za Zhi; 2006 Mar 15; 28(3):192-5. PubMed ID: 16875603
    [Abstract] [Full Text] [Related]

  • 12. Breast carcinogenesis. Transition from hyperplasia to invasive lesions.
    Meteoglu I, Dikicioglu E, Erkus M, Culhaci N, Kacar F, Ozkara E, Uyar M.
    Saudi Med J; 2005 Dec 15; 26(12):1889-96. PubMed ID: 16380768
    [Abstract] [Full Text] [Related]

  • 13. p53 protein expression and nuclear DNA content in breast intraductal proliferations.
    Schmitt FC, Leal C, Lopes C.
    J Pathol; 1995 Jul 15; 176(3):233-41. PubMed ID: 7674086
    [Abstract] [Full Text] [Related]

  • 14. [Clonality of the peripheral papilloma and cancerous cells of breast].
    Niu Y, Yu Q, Yu Y, Ding XM, Shi YR.
    Zhonghua Yi Xue Za Zhi; 2007 Feb 27; 87(8):542-5. PubMed ID: 17459204
    [Abstract] [Full Text] [Related]

  • 15. Atypical ductal hyperplasia and ductal carcinoma in situ of the breast associated with perineural invasion.
    Gobbi H, Jensen RA, Simpson JF, Olson SJ, Page DL.
    Hum Pathol; 2001 Aug 27; 32(8):785-90. PubMed ID: 11521220
    [Abstract] [Full Text] [Related]

  • 16. Correlation of p53 mutations in ThinPrep-processed fine needle breast aspirates with surgically resected breast cancers.
    Pollett A, Bedard YC, Li SQ, Rohan T, Kandel R.
    Mod Pathol; 2000 Nov 27; 13(11):1173-9. PubMed ID: 11106073
    [Abstract] [Full Text] [Related]

  • 17. Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns.
    Boecker W, Buerger H, Schmitz K, Ellis IA, van Diest PJ, Sinn HP, Geradts J, Diallo R, Poremba C, Herbst H.
    J Pathol; 2001 Nov 27; 195(4):415-21. PubMed ID: 11745672
    [Abstract] [Full Text] [Related]

  • 18. Analysis of the progression of intraductal proliferative lesions in the breast by PCR-based clonal assay.
    Yu Q, Niu Y, Yu Y, Ding X, Shi Y.
    Breast Cancer Res Treat; 2009 Apr 27; 114(3):433-40. PubMed ID: 18425676
    [Abstract] [Full Text] [Related]

  • 19. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R, Schaaf A.
    Int J Oncol; 2009 Jan 27; 34(1):15-23. PubMed ID: 19082473
    [Abstract] [Full Text] [Related]

  • 20. Clonal analysis of predominantly intraductal carcinoma and precancerous lesions of the breast by means of polymerase chain reaction.
    Noguchi S, Motomura K, Inaji H, Imaoka S, Koyama H.
    Cancer Res; 1994 Apr 01; 54(7):1849-53. PubMed ID: 7907946
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.